期刊文献+

pEGFP—C1-HSP27真核表达载体的构建及其稳定转染人胰腺癌SW1990细胞株的筛选 被引量:1

Construction of pEGFP-C1-HSP27 recombinant eukaryotic expression vector and screening of human pancreatic cancer SW1990 cell line stably expressing HSP27
原文传递
导出
摘要 目的构建表达热休克蛋白27(HSP27)的携带增强型绿色荧光蛋白(EGFP)的真核载体,建立稳定表达HSP72的人胰腺癌SW1990细胞株。方法采用RT—PCR法从SW1990细胞中扩增出带有BamHI、Hind Ⅲ酶切位点的HSP27基因片段,插入真核表达载体pEGFP—C1,鉴定正确后用重组质粒转染SW1990细胞,并筛选稳转细胞株。荧光显微镜观察HSP72的定位,RT—PCR、蛋白质印迹法检测转染细胞HSP27的表达。结果双酶切法鉴定和测序证实重组载体pEGFP—C1一HSP27的DNA序列完全正确,并成功转染SW1990细胞,筛选获得稳转细胞株。荧光显微镜见EGFP主要分布在胞质中,转染细胞的HSP27 mRNA表达明显增加(1.458±0.160比0.897±0.051,P〈0.05),且表达HSP27与EGFP的融合蛋白。结论成功构建真核表达载体pEGFP—C1-HSP27,并筛选获得稳转的细胞株。 Objective To construct pEGFP-C1-HSP27 recombinant eukaryotic expression vector and establish human pancreatic cancer SW1990 cell line stably expressing HSP27. Methods RT-PCR was applied to amplify human HSP27 cDNA from human pancreatic cancer SW1990 cells with a pair of specific primers carrying a restriction enzyme site BamH I or Hind 111 on each 5' end. HSP27 cDNA was inserted into pEGFP- C1 vector and then identified by restriction enzyme digestion and sequencing. Successful constructed pEGFP- C1-HSP27 or empty vector was transfected into SW1990 cells by lipofectamine 2000, respectively. The location of HSP72 was determined by fluoroscopy, RT-PCR and Western blot was used to detect the expression of HSP27 in transfected cell. Results The DNA sequence of pEGFP-C1-HSP27 recombinant plasmid was completely correct, and it was successfully transfected into SW1990 cell lines and stably transfected SW1990 cell lines were obtained, which were confirmed by restriction enzyme and sequencing. The expression of EGFP was distributed in cytoplasm, the HSP27mRNA expression was significantly increased (1.458 ± 0. 160 vs 0. 897±0.051, P 〈0.05). In addition, it was showed that EGFP-HSP27 fusion protein was expressed. Conclusions The eukaryotic expression vector pEGFP-C1-HSP27 was constructed successfully and stably transfected SW1990 cell line expressing HSP27 was obtained.
出处 《中华胰腺病杂志》 CAS 2012年第3期177-180,共4页 Chinese Journal of Pancreatology
基金 国家自然科学基金(81071816)
关键词 胰腺肿瘤 热休克蛋白类 转染 SW1990细胞株 基因携带体 Pancreatic neoplasms Heat-shock proteins Transfection SW1990 cell line Genetic carriers
  • 相关文献

参考文献2

二级参考文献25

  • 1宋海燕,刘银坤,崔杰峰,张丽君,代智,冯钜涛,冯久贤,申华莉,杨芃原.人肝细胞性肝癌组织转移相关分子的比较蛋白质组学研究[J].中华肝脏病杂志,2005,13(5):331-334. 被引量:21
  • 2冯钜涛,刘银坤,代智,周海军,宋海燕,钦伦秀,金红,陆豪杰,汤钊猷.血清蛋白质组分析技术筛选肝癌自发抗体[J].中华肝脏病杂志,2005,13(11):832-835. 被引量:13
  • 3Sohail MA,Saif MW.Role of anticoagulation in the management of pancreatic cancer.JOP,2009,10:82-87.
  • 4Riess H,Pelzer U,Deutschinoff G,et al.A prospective,randomized trial of chemotherapy with or without the low molecular weight heparin enoxaparin in patients with advanced pancreatic cancer:Results of the CONKO 004 trial.J Clin Oncol,2009,27:4506.
  • 5Riess H,Pelzer U,Hilbig A,et al.Rationale and design of PROSPECT-CONKO 004:a prospective,randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy.BMC Cancer,2008,8:361.
  • 6Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial.J Clin Oncol,1997,15:2403-2413.
  • 7Heinemann V,Labianca R,Hinke A,et al.Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer:pooled analysis of two randomized trials,the GERCOR/GISCAD intergroup study and a German multicenter study.Ann Oncol,2007,18:1652-1659.
  • 8Heinemann V,Boeck S,Hinke A,et al.Meta-analysis of randomized trials:evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.BMC Cancer,2008,8:82.
  • 9Colucci G,Labianca R,Di Costanzo F,et al.A randomized trial of gemcitabine (G) versus G plus cisplatin in chemotherapy-naive advanced pancreatic adenocarcinoma:The GIP-1 (Gruppo Italiano Pancreas-GOIM/GISCAD/GOIRC) study.J Clin Oncol,2009,27:4504.
  • 10Bernhardt SL,Gjertsen MK,Trachsel S,et al.Telomerase peptide vaccination of patients with non-resectable pancreatic cancer:A dose escalating phase Ⅰ / Ⅱ study.Br J Cancer,2006,95:1474-1482.

共引文献10

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部